RespireRx Pharmaceuticals Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
RespireRx Pharmaceuticals Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2023.
  • RespireRx Pharmaceuticals Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 298M shares, a 149% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 298M +179M +149% Sep 30, 2023 10-Q 2023-11-17
Q2 2023 221M +104M +88.5% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 221M +123M +125% Mar 31, 2023 10-Q 2023-08-21
Q4 2022 126M +27.7M +28.2% Dec 31, 2022 10-Q 2023-11-17
Q3 2022 120M Sep 30, 2022 10-Q 2022-11-17
Q2 2022 117M +26.7M +29.5% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 97.9M +8.4M +9.38% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 97.9M +26.6M +37.4% Dec 31, 2021 10-K 2023-04-17
Q2 2021 90.4M -132M -59.3% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 89.5M +55.8M +166% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 71.3M +70.9M +16971% Dec 31, 2020 10-Q 2021-08-16
Q3 2020 578M +574M +14794% Sep 30, 2020 10-Q 2020-11-23
Q2 2020 222M +218M +5641% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 33.7M +29.8M +770% Mar 31, 2020 10-Q 2020-05-20
Q4 2019 418K -3.45M -89.2% Dec 31, 2019 10-K 2021-04-15
Q3 2019 3.88M +291K +8.11% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 3.87M +522K +15.6% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 3.87M +749K +24% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 3.87M +807K +26.3% Dec 31, 2018 10-K 2020-04-14
Q3 2018 3.59M +1M +38.7% Sep 30, 2018 10-Q 2018-11-16
Q2 2018 3.35M +1.06M +46.3% Jun 30, 2018 10-Q 2018-10-15
Q1 2018 3.12M +834K +36.4% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 3.07M +916K +42.6% Dec 31, 2017 10-K 2019-04-16
Q3 2017 2.59M +568K +28.1% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 2.29M -654M -99.7% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 2.29M -496M -99.5% Mar 31, 2017 10-Q 2017-05-19
Q4 2016 2.15M +642K +42.6% Dec 31, 2016 10-K 2018-04-17
Q3 2016 2.02M -475M -99.6% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 656M +243M +58.7% Jun 30, 2016 10-Q/A 2016-08-12
Q1 2016 499M +258M +107% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 1.51M -231M -99.4% Dec 31, 2015 10-K 2017-03-31
Q3 2015 477M +267M +127% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 413M 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 241M +39.8M +19.8% Mar 31, 2015 10-Q/A 2015-08-07
Q4 2014 232M +88.1M +61.2% Dec 31, 2014 10-K 2016-03-29
Q3 2014 210M +66.4M +46.1% Sep 30, 2014 10-Q 2015-03-09
Q2 2014 413M +269M +187% Jun 30, 2014 10-Q 2015-08-13
Q1 2014 201M +57M +39.6% Mar 31, 2014 10-Q 2015-02-10
Q4 2013 144M 0 0% Dec 31, 2013 10-K 2015-03-30
Q3 2013 144M -2 0% Sep 30, 2013 10-Q 2014-12-15
Q2 2013 144M +58.4M +68.2% Jun 30, 2013 10-Q 2014-12-15
Q1 2013 144M +58.4M +68.2% Mar 31, 2013 10-Q 2014-11-24
Q4 2012 144M +58.4M +68.2% Dec 31, 2012 10-K 2015-01-06
Q3 2012 144M +65.2M +82.7% Sep 30, 2012 10-Q 2014-07-30
Q2 2012 85.6M +6.77M +8.58% Jun 30, 2012 10-Q 2012-08-16
Q1 2012 85.6M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 85.6M +6.77M +8.58% Dec 31, 2011 10-K 2014-10-14
Q3 2011 78.9M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 78.9M Jun 30, 2011 10-Q 2011-08-18
Q4 2010 78.9M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.